GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Biotage AB (OSTO:BIOT) » Definitions » Cyclically Adjusted PS Ratio

Biotage AB (OSTO:BIOT) Cyclically Adjusted PS Ratio : 9.65 (As of May. 17, 2024)


View and export this data going back to 2000. Start your Free Trial

What is Biotage AB Cyclically Adjusted PS Ratio?

As of today (2024-05-17), Biotage AB's current share price is kr179.50. Biotage AB's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was kr18.60. Biotage AB's Cyclically Adjusted PS Ratio for today is 9.65.

The historical rank and industry rank for Biotage AB's Cyclically Adjusted PS Ratio or its related term are showing as below:

OSTO:BIOT' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 4.95   Med: 12.85   Max: 23.25
Current: 9.14

During the past years, Biotage AB's highest Cyclically Adjusted PS Ratio was 23.25. The lowest was 4.95. And the median was 12.85.

OSTO:BIOT's Cyclically Adjusted PS Ratio is ranked worse than
84.14% of 473 companies
in the Medical Devices & Instruments industry
Industry Median: 2.19 vs OSTO:BIOT: 9.14

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Biotage AB's adjusted revenue per share data for the three months ended in Mar. 2024 was kr5.995. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is kr18.60 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Biotage AB Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Biotage AB's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biotage AB Cyclically Adjusted PS Ratio Chart

Biotage AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 12.62 12.65 20.60 11.61 7.33

Biotage AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.05 7.85 6.12 7.33 9.78

Competitive Comparison of Biotage AB's Cyclically Adjusted PS Ratio

For the Medical Instruments & Supplies subindustry, Biotage AB's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biotage AB's Cyclically Adjusted PS Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Biotage AB's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Biotage AB's Cyclically Adjusted PS Ratio falls into.



Biotage AB Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Biotage AB's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=179.50/18.6
=9.65

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biotage AB's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Biotage AB's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=5.995/132.2054*132.2054
=5.995

Current CPI (Mar. 2024) = 132.2054.

Biotage AB Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 1.860 100.432 2.448
201409 1.832 100.161 2.418
201412 2.129 100.225 2.808
201503 2.228 99.950 2.947
201506 2.289 99.995 3.026
201509 2.313 100.228 3.051
201512 2.604 100.276 3.433
201603 2.455 100.751 3.221
201606 2.517 101.019 3.294
201609 2.581 101.138 3.374
201612 2.768 102.022 3.587
201703 2.862 102.022 3.709
201706 3.034 102.752 3.904
201709 2.746 103.279 3.515
201712 2.919 103.793 3.718
201803 3.215 103.962 4.088
201806 3.648 104.875 4.599
201809 3.588 105.679 4.489
201812 3.625 105.912 4.525
201903 3.808 105.886 4.755
201906 4.327 106.742 5.359
201909 4.335 107.214 5.345
201912 4.426 107.766 5.430
202003 4.253 106.563 5.276
202006 3.899 107.498 4.795
202009 4.033 107.635 4.954
202012 4.569 108.296 5.578
202103 4.308 108.360 5.256
202106 4.642 108.928 5.634
202109 4.668 110.338 5.593
202112 5.181 112.486 6.089
202203 5.832 114.825 6.715
202206 5.971 118.384 6.668
202209 6.058 122.296 6.549
202212 5.801 126.365 6.069
202303 5.455 127.042 5.677
202306 5.877 129.407 6.004
202309 5.604 130.224 5.689
202312 8.029 131.912 8.047
202403 5.995 132.205 5.995

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Biotage AB  (OSTO:BIOT) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Biotage AB Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Biotage AB's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Biotage AB (OSTO:BIOT) Business Description

Traded in Other Exchanges
Address
Vimpelgatan 5, Box 8, Uppsala, SWE, 751 03
Biotage AB provides separation technology and solutions for analytical and organic chemistry from research to commercial analytical laboratories and industrial applications. Its customers span a broad range of market segments including pharmaceutical, biotech, diagnostic, contract research, and contract manufacturers as well as clinical, forensic, and academic laboratories in addition to organizations focused on food safety, clean water, and environmental sustainability. It serves three geographic markets: The Americas, APAC (Asia-Pacific,) and EMEA (Europe, Middle East & Africa). The company's product areas include Small Molecules & Synthetic Therapeutics, Biologics & Advanced Therapeutics, Scale-Up, Diagnostics, Analytical Testing, and Water & Environmental Testing.

Biotage AB (OSTO:BIOT) Headlines

From GuruFocus

Biotech Acquisition Company Announces Liquidation

By GlobeNewswire GlobeNewswire 02-02-2023

Biotech Acquisition Company Announces Liquidation

By Stock market mentor Stock market mentor 02-02-2023